Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,129 | -7,280 | -4,689 | -17,510 | -23,214 |
| Depreciation Amortization | 1,909 | 1,895 | 2,301 | 1,233 | 696 |
| Income taxes - deferred | 52 | 61 | 34 | 41 | 14,320 |
| Accounts receivable | 7,457 | 4,381 | -7,730 | 1,100 | -4,218 |
| Other Working Capital | 246 | 758 | -137 | -1,997 | 5,117 |
| Other Operating Activity | -5,055 | -3,084 | 10,646 | 82 | 5,728 |
| Operating Cash Flow | $-4,520 | $-3,269 | $425 | $-17,051 | $-1,571 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -981 | -775 | -2,272 | -1,864 | -1,431 |
| Purchase Of Investment | N/A | N/A | N/A | -19,977 | -76,970 |
| Sale Of Investment | N/A | N/A | 9,981 | 35,291 | 51,773 |
| Purchase Sale Intangibles | N/A | -100 | N/A | N/A | -70 |
| Other Investing Activity | 0 | -100 | 0 | 0 | -70 |
| Investing Cash Flow | $-981 | $-875 | $7,709 | $13,450 | $-26,698 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 29,340 | 4,468 | 14,047 | 17,225 | 13,800 |
| Common Stock Issued | 532 | 727 | 3,086 | 1,244 | 43,120 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -16,399 |
| Dividend Paid | N/A | N/A | N/A | -689 | -689 |
| Other Financing Activity | -27,488 | -916 | -19,047 | -12,225 | -16,480 |
| Financing Cash Flow | $2,384 | $4,279 | $-1,914 | $5,555 | $23,352 |
| Exchange Rate Effect | -214 | -245 | 184 | 178 | -54 |
| Beginning Cash Position | 14,566 | 14,676 | 8,272 | 6,140 | 11,111 |
| End Cash Position | 11,235 | 14,566 | 14,676 | 8,272 | 6,140 |
| Net Cash Flow | $-3,331 | $-110 | $6,404 | $2,132 | $-4,971 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,520 | -3,269 | 425 | -17,051 | -1,571 |
| Capital Expenditure | -981 | -775 | -2,325 | -1,864 | -1,431 |
| Free Cash Flow | -5,501 | -4,044 | -1,900 | -18,915 | -3,002 |